SCHEMBL7980299

SCHEMBL7980299

Cc1cccc(Nc2nc3ccccc3n3cncc23)c1C

nearest known ligand 0.75

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
LCK P06239 19/20 0.75
LYN P07948 1/20 0.57
BTK Q06187 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7969745 0.88 LCK (0.80) LCK
SCHEMBL7980767 0.86 LCK (1.00) LCK
SCHEMBL7982979 0.81 LCK (0.79) LCKLYNBTK
SCHEMBL7969689 0.81 LCK (0.75) LCKLYNBTK
SCHEMBL7984726 0.81 LCK (0.72) LCKLYNBTK
SCHEMBL7979866 0.81 LCK (1.00) LCK
SCHEMBL7981902 0.81 LCK (1.00) LCKLYNBTK
SCHEMBL7969709 0.81 LCK (1.00) LCK
SCHEMBL7969573 0.80 LCK (0.67) LCKLYNBTK
SCHEMBL7969915 0.80 LCK (1.00) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed